0001127602-21-009288.txt : 20210303 0001127602-21-009288.hdr.sgml : 20210303 20210303192334 ACCESSION NUMBER: 0001127602-21-009288 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210301 FILED AS OF DATE: 20210303 DATE AS OF CHANGE: 20210303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JONAS DANIEL CENTRAL INDEX KEY: 0001238334 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39218 FILM NUMBER: 21711586 MAIL ADDRESS: STREET 1: C/O CONMED CORP STREET 2: 525 FRENCH ROAD CITY: UTICA STATE: NY ZIP: 13502-5994 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CONMED CORP CENTRAL INDEX KEY: 0000816956 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 160977505 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 525 FRENCH ROAD CITY: UTICA STATE: NY ZIP: 13502 BUSINESS PHONE: 315-624-3208 MAIL ADDRESS: STREET 1: 525 FRENCH ROAD CITY: UTICA STATE: NY ZIP: 13502 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2021-03-01 0000816956 CONMED CORP CNMD 0001238334 JONAS DANIEL C/O CONMED CORP 11311 CONCEPT BOULEVARD LARGO FL 33773 1 EVP Legal Affairs,Gen. Counsel Common Stock 2021-03-01 4 M 0 3221 39.87 A 16929 D Common Stock 2021-03-01 4 S 0 3221 123.2596 D 13708 D Common Stock 2021-03-01 4 M 0 624 41.93 A 14332 D Common Stock 2021-03-01 4 S 0 624 123.2752 D 13708 D Common Stock 2021-03-01 4 M 0 3500 41.93 A 17208 D Common Stock 2021-03-01 4 F 0 2345 123.20 D 14863 D Common Stock 2021-03-02 4 M 0 2199 39.87 A 17062 D Common Stock 2021-03-02 4 S 0 2199 121.8437 D 14863 D Common Stock 2021-03-02 4 M 0 1000 41.93 A 15863 D Common Stock 2021-03-02 4 S 0 1000 121.9194 D 14863 D Common Stock 2021-03-02 5 G 0 E 800 0 D 14063 D Common Stock 2021-03-02 5 G 0 E 150 0 D 13913 D Common Stock 2021-03-02 5 G 0 E 150 0 D 13763 D Common Stock 2021-03-02 5 G 0 E 150 0 A 450 I daughter Options To Purchase Common Stock 39.87 2021-03-01 4 M 0 3221 0 D 2026-03-01 Common Stock 3221 2199 D Options To Purchase Common Stock 41.93 2021-03-01 4 M 0 624 0 D 2027-03-01 Common Stock 624 24376 D Options To Purchase Common Stock 41.93 2021-03-01 4 M 0 3500 0 D 2027-03-01 Common Stock 3500 20876 D Options To Purchase Common Stock 122.55 2021-03-01 4 A 0 21250 0 A 2031-03-01 Common Stock 21250 21250 D Options To Purchase Common Stock 39.87 2021-03-02 4 M 0 2199 0 D 2026-03-01 Common Stock 2199 0 D Options To Purchase Common Stock 41.93 2021-03-02 4 M 0 1000 0 D 2027-03-01 Common Stock 1000 19876 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.25 to $123.49. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.25 to $123.405. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.80 to $122.22. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.80 to $122.33. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Daniel S. Jonas 2021-03-03